Clinical trial
Study of CNGB1 Retinitis Pigmentosa and Allied Hereditary Disorders
NCT04639635 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of CNGB1 Retinitis Pigmentosa and Allied Hereditary Disorders
- Lead sponsor
- Columbia University
- Phase
- Observational
- Overall status
- Suspended
- Start date
- March 14, 2019
- Completion date
- February 28, 2027
- Enrollment
- 20 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
retinitis pigmentosa associated with cngb1 mutations